Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, March 2006, p. 1079-1082, Vol. 50, No. 3
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.3.1079-1082.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
Longzhu Cui,1,2*
Eiji Tominaga,2
Hui-min Neoh,1 and
Keiichi Hiramatsu1,2
Department of Bacteriology,1
Department of Infection Control Science, Juntendo University, 2-1-1 Bunkyo-Ku, Tokyo, Japan 113-84212
Received 17 August 2005/
Returned for modification 18 October 2005/
Accepted 27 December 2005
We present here findings of a strong positive correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus (VISA). This correlation is related to cell wall thickening, suggesting that, similar to the case with vancomycin resistance in VISA, the physical barrier of a thickened cell wall may contribute to daptomycin resistance in S. aureus.
* Corresponding author. Mailing address: Department of Bacteriology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, Japan 113-8421. Phone: (81 3) 5802-1041. Fax: (81 3) 5684-7830. E-mail: longzhu{at}med.juntendo.ac.jp.
Antimicrobial Agents and Chemotherapy, March 2006, p. 1079-1082, Vol. 50, No. 3
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.3.1079-1082.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Hawkey, P. M.
(2008). Pre-clinical experience with daptomycin. J Antimicrob Chemother
62: iii7-iii14
[Abstract]
[Full Text]
-
Seaton, R. A.
(2008). Daptomycin: rationale and role in the management of skin and soft tissue infections. J Antimicrob Chemother
62: iii15-iii23
[Abstract]
[Full Text]
-
Warren, R. E.
(2008). Daptomycin in endocarditis and bacteraemia: a British perspective. J Antimicrob Chemother
62: iii25-iii33
[Abstract]
[Full Text]
-
Livermore, D. M.
(2008). Future directions with daptomycin. J Antimicrob Chemother
62: iii41-iii49
[Abstract]
[Full Text]
-
Murthy, M. H., Olson, M. E., Wickert, R. W., Fey, P. D., Jalali, Z.
(2008). Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate. J Med Microbiol
57: 1036-1038
[Abstract]
[Full Text]
-
Chua, T., Moore, C. L., Perri, M. B., Donabedian, S. M., Masch, W., Vager, D., Davis, S. L., Lulek, K., Zimnicki, B., Zervos, M. J.
(2008). Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates in Urban Detroit. J. Clin. Microbiol.
46: 2345-2352
[Abstract]
[Full Text]
-
Hidron, A. I., Schuetz, A. N., Nolte, F. S., Gould, C. V., Osborn, M. K.
(2008). Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis. J Antimicrob Chemother
61: 1394-1396
[Full Text]
-
Rose, W. E., Leonard, S. N., Sakoulas, G., Kaatz, G. W., Zervos, M. J., Sheth, A., Carpenter, C. F., Rybak, M. J.
(2008). Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations. Antimicrob. Agents Chemother.
52: 831-836
[Abstract]
[Full Text]
-
Muthaiyan, A., Silverman, J. A., Jayaswal, R. K., Wilkinson, B. J.
(2008). Transcriptional Profiling Reveals that Daptomycin Induces the Staphylococcus aureus Cell Wall Stress Stimulon and Genes Responsive to Membrane Depolarization. Antimicrob. Agents Chemother.
52: 980-990
[Abstract]
[Full Text]
-
Montero, C. I., Stock, F., Murray, P. R.
(2008). Mechanisms of Resistance to Daptomycin in Enterococcus faecium. Antimicrob. Agents Chemother.
52: 1167-1170
[Abstract]
[Full Text]
-
Huang, Y.-T., Hsiao, C.-H., Liao, C.-H., Lee, C.-W., Hsueh, P.-R.
(2008). Bacteremia and Infective Endocarditis Caused by a Non-Daptomycin-Susceptible, Vancomycin-Intermediate, and Methicillin-Resistant Staphylococcus aureus Strain in Taiwan. J. Clin. Microbiol.
46: 1132-1136
[Abstract]
[Full Text]
-
Neoh, H.-m., Cui, L., Yuzawa, H., Takeuchi, F., Matsuo, M., Hiramatsu, K.
(2008). Mutated Response Regulator graR Is Responsible for Phenotypic Conversion of Staphylococcus aureus from Heterogeneous Vancomycin-Intermediate Resistance to Vancomycin-Intermediate Resistance. Antimicrob. Agents Chemother.
52: 45-53
[Abstract]
[Full Text]
-
Moise, P. A., Smyth, D. S., El-Fawal, N., Robinson, D. A., Holden, P. N., Forrest, A., Sakoulas, G.
(2008). Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother
61: 85-90
[Abstract]
[Full Text]
-
Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S.-J., Proctor, R. A., Sahl, H.-G., Schrenzel, J., Xiong, Y. Q., Bayer, A. S.
(2008). Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding. Antimicrob. Agents Chemother.
52: 269-278
[Abstract]
[Full Text]
-
Sakoulas, G., Rose, W., Rybak, M. J., Pillai, S., Alder, J., Moellering, R. C. Jr., Eliopoulos, G. M.
(2008). Evaluation of Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus Developing Nonsusceptibility to Daptomycin. J. Clin. Microbiol.
46: 220-224
[Abstract]
[Full Text]
-
Julian, K., Kosowska-Shick, K., Whitener, C., Roos, M., Labischinski, H., Rubio, A., Parent, L., Ednie, L., Koeth, L., Bogdanovich, T., Appelbaum, P. C.
(2007). Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis. Antimicrob. Agents Chemother.
51: 3445-3448
[Abstract]
[Full Text]
-
Cheng, J., Thanassi, J. A., Thoma, C. L., Bradbury, B. J., Deshpande, M., Pucci, M. J.
(2007). Dual Targeting of DNA Gyrase and Topoisomerase IV: Target Interactions of Heteroaryl Isothiazolones in Staphylococcus aureus. Antimicrob. Agents Chemother.
51: 2445-2453
[Abstract]
[Full Text]
-
Pillai, S. K., Gold, H. S., Sakoulas, G., Wennersten, C., Moellering, R. C. Jr., Eliopoulos, G. M.
(2007). Daptomycin Nonsusceptibility in Staphylococcus aureus with Reduced Vancomycin Susceptibility Is Independent of Alterations in MprF. Antimicrob. Agents Chemother.
51: 2223-2225
[Abstract]
[Full Text]
-
Mwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de Lencastre, H., Richardson, P., Bruce, D., Rubin, E., Myers, E., Siggia, E. D., Tomasz, A.
(2007). Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. USA
104: 9451-9456
[Abstract]
[Full Text]
-
Credito, K., Lin, G., Appelbaum, P. C.
(2007). Activity of Daptomycin Alone and in Combination with Rifampin and Gentamicin against Staphylococcus aureus Assessed by Time-Kill Methodology. Antimicrob. Agents Chemother.
51: 1504-1507
[Abstract]
[Full Text]
-
Credito, K., Lin, G., Appelbaum, P. C.
(2007). Antistaphylococcal Activity of DX-619 Alone and in Combination with Vancomycin, Teicoplanin, and Linezolid Assessed by Time-Kill Synergy Testing. Antimicrob. Agents Chemother.
51: 1508-1511
[Abstract]
[Full Text]
-
Tsuji, B. T., Rybak, M. J., Lau, K. L., Sakoulas, G.
(2007). Evaluation of Accessory Gene Regulator (agr) Group and Function in the Proclivity towards Vancomycin Intermediate Resistance in Staphylococcus aureus. Antimicrob. Agents Chemother.
51: 1089-1091
[Abstract]
[Full Text]
-
Goldstein, F.
(2007). The potential clinical impact of low-level antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother
59: 1-4
[Abstract]
[Full Text]
-
French, G. L.
(2006). Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. J Antimicrob Chemother
58: 1107-1117
[Abstract]
[Full Text]
-
Wootton, M., MacGowan, A. P., Walsh, T. R.
(2006). Comparative Bactericidal Activities of Daptomycin and Vancomycin against Glycopeptide-Intermediate Staphylococcus aureus (GISA) and Heterogeneous GISA Isolates. Antimicrob. Agents Chemother.
50: 4195-4197
[Abstract]
[Full Text]
-
Diederen, B. M. W., van Duijn, I., Willemse, P., Kluytmans, J. A. J. W.
(2006). In Vitro Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus, Including Heterogeneously Glycopeptide-Resistant Strains.. Antimicrob. Agents Chemother.
50: 3189-3191
[Abstract]
[Full Text]
-
Jevitt, L. A., Thorne, G. M., Traczewski, M. M., Jones, R. N., McGowan, J. E. Jr., Tenover, F. C., Brown, S. D.
(2006). Multicenter Evaluation of the Etest and Disk Diffusion Methods for Differentiating Daptomycin-Susceptible from Non-Daptomycin-Susceptible Staphylococcus aureus Isolates.. J. Clin. Microbiol.
44: 3098-3104
[Abstract]
[Full Text]
-
Green, M. R, Anasetti, C., Sandin, R. L, Rolfe, N. E, Greene, J. N
(2006). Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans. J Oncol Pharm Pract
12: 179-181
[Abstract]
-
Mariani, P. G., Sader, H. S., Jones, R. N.
(2006). Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy. J Antimicrob Chemother
58: 481-483
[Full Text]
Copyright © 2006 by the American Society for Microbiology. All rights reserved.